A Multicenter, Randomized, Non-Comparative, Phase II Study of Nivolumab ± Ipilimumab for Patients with Metastatic Sarcoma (alliance A091401): Expansion Cohorts and Correlative Analyses
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2024）
Key words
Immunotherapy,Biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined